Y. Bao

国产达沙替尼二线治疗慢性髓性白血病慢性期患者的疗效和安全性分析

L. Meng, Z. Zhao, Y. L. Chen, 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Efficacy and Safety of Generic Dasatinib as a Second-line Treatment for Patients with Chronic Myeloid Leukemia: a Multicenter Retrospective Study in Hubei Province, China

L. Meng, P. Zou, Z. Zhong, 2018, Current Medical Science.

Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.

Hesheng Luo, Youhong Dong, Y. Bao, 2018, Cancer biotherapy & radiopharmaceuticals.

Comparison of clinical remission and survival between CLAG and FLAG induction chemotherapy in patients with refractory or relapsed acute myeloid leukemia: a prospective cohort study

Y. Bao, J. Zhao, Z-Z Li, 2017, Clinical and Translational Oncology.

Recommendations for standardized management of CML patients in the core epidemic area of COVID-19(Multi-center survey results in Hubei Province, China)

Q. Li, D. Wang, X. Zuo, 2020, medRxiv.

The First Report of the Prevalence of COVID-19 in Chronic Myelogenous Leukemia Patients in the Core Epidemic Area of China: A Multicentre, Cross-Sectional Survey

L. Meng, Youlin Zhao, Zhuangzhi Yang, 2020 .

COVID-19 in persons with chronic myeloid leukaemia

Q. Jiang, Zhuangzhi Yang, Hongxiang Wang, 2020, Leukemia.

MicroRNA‐146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients

Y. Bao, Xiaohong Ji, Mingqin Wei, 2020, Journal of clinical laboratory analysis.